MDoutlook is a leading disease intelligence company.
We build the success of your organization through better decision-making.
Specializing in oncology, rare and ultra-rare diseases, we answer your business questions using custom market research instruments, our proprietary disease panels, our client side experience and our depth of clinical understanding.
Driven by staff medical experts, our team engages with ThoughtLeaders and the right clinicians to deliver real-world, actionable insights.
MDoutlook provides custom and syndicated market research, ThoughtLeader identification and network mapping, and guaranteed physician engagement.
Click on the above icons to explore how our clients derive value.
What's New at MDoutlook
13 Feb 2019
Later this month, MDoutlook will release results from the latest wave of their global leadership study. Using ONCpulse™, we engaged with a robust sample of…
08 Oct 2018
Since 1901 the Nobel Prize for Physiology and Medicine has been awarded to 216 Laureates. In total, 122 different discoveries have been endowed; 36 of which…